NuWays AG Affirms Buy Rating for Nynomic AG Amid Challenges

NuWays AG has maintained its 'Buy' recommendation for Nynomic AG, following the release of Q4 figures and FY25 guidance. Despite preliminary Q4 sales of €30.5m, a 12% decline from the previous year, the company's guidance reflects a return to growth. However, FY25 growth projections are below market expectations due to ongoing macroeconomic challenges.

The cautious FY25 outlook anticipates €105-110m in sales and €8.5-10m in EBIT, which is conservative compared to market forecasts. Nevertheless, management remains optimistic about reaching mid-term targets of at least €200m in sales with a 16-19% EBIT margin.

Nynomic plans to achieve this through organic growth in core markets and strategic acquisitions. The company is engaged in several M&A processes, with a focus on expanding its technological and geographical reach.